We are live on ! Find out more
DTC

Deep Track Capital Portfolio holdings

AUM $6.87B
1-Year Est. Return 205.24%
This Fund
S&P 500
This Quarter Est. Return
+3.27%
1 Year Est. Return
+205.24%
3 Year Est. Return
+440.18%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.41B
Cap. Flow %
99.82%
Top 10 Hldgs %
42.68%
Holding
55
New
55
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$69M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$65.7M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$65.6M
4
KROS icon
Keros Therapeutics
KROS
+$64.8M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$62M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.41%
2 Miscellaneous 4.49%
3 Real Estate 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPSC icon
51
Century Therapeutics
IPSC
$355M
$3.96M 0.28%
+250,000
New +$4.7M
CNTB
52
Connect Biopharma Holdings
CNTB
$82.5M
$3.33M 0.24%
+647,057
New +$7.19M
ONCR
53
DELISTED
Oncorus, Inc.
ONCR
$3.16M 0.22%
+600,000
New +$4.65M
ALNY icon
54
PUT
Alnylam Pharmaceuticals
ALNY
$32.2B
$1.98M 0.14%
+11,700
New +$2.17M
RFL icon
55
Rafael Holdings
RFL
$109M
$1.46M 0.1%
+289,714
New +$3.9M
1 2
3

Similar funds

PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
NP
NorthRock Partners Minneapolis, Minnesota $6.89B AUM 19.83% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return
RCWMU
Rothschild & Co Wealth Management (UK) London, United Kingdom $6.93B AUM 1.4% 1-Year Est. Return
CA
Cambridge Associates Boston, Massachusetts $6.93B AUM 17.96% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $6.8B AUM 23.31% 1-Year Est. Return
CI
Cincinnati Insurance Fairfield, Ohio $6.94B AUM 20.24% 1-Year Est. Return

Deep Track Capital's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Deep Track Capital, which disclosed 55 positions worth $1.42B. Its ten largest holdings account for 43% of the portfolio.

Its largest position is Travere Therapeutics: 2,450,000 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Miscellaneous and Real Estate.

  • Deep Track Capital's largest Q4 2021 buy was Travere Therapeutics: 2,450,000 shares worth $76M.
  • Deep Track Capital's ten largest holdings make up 43% of its $1.42B portfolio in Q4 2021.
  • Deep Track Capital disclosed 55 positions in Q4 2021, its first 13F filing on record.

Based on Deep Track Capital's 13F filing for Q4 2021, filed 14 Feb 2022.